资讯

'ZDNET Recommends': What exactly does it mean? ZDNET's recommendations are based on many hours of testing, research, and comparison shopping. We gather data from the best available sources, including ...
From skirt lengths to satellite images to a blockchain tracker, here are 11 quirky and serious indicators you can use to sanity-check the new inflation and employment numbers. In 2025, trust in ...
Forbes contributors publish independent expert analyses and insights. Kate O’Flaherty is a cybersecurity and privacy journalist.
The administration has become increasingly focused on admissions data in its effort to bring the higher education system in line with President Trump’s political agenda. By Michael C. Bender and ...
Julius AI, a startup that describes itself as an AI data analyst, announced it has raised a $10 million seed round led by Bessemer Venture Partners. Horizon VC, 8VC, Y Combinator, and the AI Grant ...
23andMe, the company whose mail-in self-testing kits became synonymous with DNA testing, is filing for bankruptcy. Anne Wojcicki, who co-founded 23andMe in 2006, is stepping down as CEO as the company ...
The genetic testing company 23andMe — which allows users to spit in a tube and send away the sample for a detailed DNA analysis — is filing for bankruptcy. 23andMe has faced financial hardship for ...
Firefox maker Mozilla deleted a promise to never sell its users' personal data and is trying to assure worried users that its approach to privacy hasn't fundamentally changed. Until recently, a ...
Synthetic biologists from Yale were able to re-write the genetic code of an organism — a novel genomically recoded organism (GRO) with one stop codon — using a cellular platform that they developed ...
Amazon, Google, Meta, Microsoft and other big, well-known technology companies are buying up dozens of acres of land in Ohio and announcing plans to build vast data centers. It's a trend that is ...
MENLO PARK, Calif.--(BUSINESS WIRE)--ReCode Therapeutics, a clinical-stage genetic medicines company using tissue-specific delivery to power the next wave of mRNA and gene correction therapeutics, ...